山口照英 (Teruhide Yamaguchi) - マイポータル

基本情報

所属: 金沢工業大学金沢工業大学金沢工大研究センター加齢医工学先端技術研究所特任教授 (加齢医工学先端技術研究所所長)

学位: 理学博士(神戸大学)

J-GLOBAL ID: 200901000164079943
researchmap会員ID: 0000041250

研究キーワード

研究分野

ライフサイエンス / 細胞生物学 /

学歴

論文

157

Quality and Safety Considerations for Therapeutic Products Based on Extracellular Vesicles.

Yoshinobu Takakura, Rikinari Hanayama, Kazunari Akiyoshi, Shiroh Futaki, Kyoko Hida, Takanori Ichiki, Akiko Ishii-Watabe, Masahiko Kuroda, Kazushige Maki, Yasuo Miura …

Pharmaceutical research 41(8) 1573-1594 2024年8月査読有り
Polyethyleneimine-modified resins effectively remove porcine circovirus and cellular prion protein.

Mikihiro Yunoki, Takeru Urayama, Shigeyuki Aoyama, Natsuki Okaniwa, Kaoru Sakai, Eriko Uchida, Kazuyoshi Ikuta, Teruhide Yamaguchi

Journal of virological methods 294 114181-114181 2021年8月査読有り
Regulatory challenges with biosimilars: an update from 20 countries.

Hye-Na Kang, Robin Thorpe, Ivana Knezevic, Mary Casas Levano, Mumbi Bernice Chilufya, Parichard Chirachanakul, Hui Ming Chua, Dina Dalili, Freddie Foo, Kai Gao …

Annals of the New York Academy of Sciences 1491(1) 42-59 2021年5月査読有り
Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan

Teruhide Yamaguchi, Eriko Uchida, Takashi Okada, Keiya Ozawa, Masafumi Onodera, Akihiro Kume, Takashi Shimada, Satoru Takahashi, Kenzaburo Tani, Yasutomo Nasu …

Human Gene Therapy 31(19-20) 1043-1053 2020年10月1日査読有り
WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25-26 June 2019.

Meenu Wadhwa, Hye-Na Kang, Teeranart Jivapaisarnpong, Lucia Rizka Andalucia, Carolina Damas Rocha Zarate Blades, Mary Casas Levano, Weihong Chang, Jing Yin Chew, Mumbi Bernice Chilufya, Parichard Chirachanakul …

Biologicals : journal of the International Association of Biological Standardization 65 50-59 2020年5月
Comprehensive Metabolomic Analysis of IDH1^R132H Clinical Glioma Samples Reveals Suppression of β-oxidation Due to Carnitine Deficiency.

Miyata S, Tominaga K, Sakashita E, Urabe M, Onuki Y, Gomi A, Yamaguchi T, Mieno M, Mizukami H, Kume A …

Scientific reports 9(1) 9787 2019年7月査読有り
mRNA医薬品の品質・安全性評価の考え方

荒戸照世, 位髙啓文, 内田恵理子, 真木一茂, 山口照英, 井上貴夫

医薬品医療機器レギュラトリーサイエンス 50(6) 300-306 2019年
Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan

Sakurai A, Ogawa T, Matsumoto J, Kihira T, Fukushima S, Miyata I, Shimizu H, Itamura S, Ouchi K, Hamada A …

Vaccine 37(43) 6573-6579 2019年査読有り
Two-Dimensional Droplet Digital PCR as a Tool for Titration and Integrity Evaluation of Recombinant Adeno-Associated Viral Vectors.

Furuta-Hanawa, B, YAMAGUCHI TERUHIDE, Uchida, E

Hum Gene Ther Methods 30(4) 127-136 2019年査読有り
WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 27–28 April 2017

Meenu Wadhwa, Hye-Na Kang, Hugo Hamel, Teeranart Jivapaisarnpong, Mai Allam, Beverley Alway, Patricia Aprea, Carolina Blades, Parichard Chirachanakul, Sannie Chong …

Biologicals 52 83-91 2018年3月1日
Occludin as a functional marker of vascular endothelial cells on tube-forming activity

Toshie Kanayasu-Toyoda, Akiko Ishii-Watabe, Yutaka Kikuchi, Hiroko Kitagawa, Hiroko Suzuki, Hiroomi Tamura, Minoru Tada, Takuo Suzuki, Hiroyuki Mizuguchi, Teruhide Yamaguchi

JOURNAL OF CELLULAR PHYSIOLOGY 233(2) 1700-1711 2018年2月査読有り
Oncolytic virus: Regulatory aspects from quality control to clinicastudies

Teruhide Yamaguchi, Eriko Uchida

Current Cancer Drug Targets 18(2) 202-208 2018年査読有り
Endothelial Progenitors: A Consensus Statement on Nomenclature

Reinhold J. Medina, Chad L. Barber, Florence Sabatier, Francoise Dignat-George, Juan M. Melero-Martin, Kiarash Khosrotehrani, Osamu Ohneda, Anna M. Randi, Jerry K. Y. Chan, Teruhide Yamaguchi …

STEM CELLS TRANSLATIONAL MEDICINE 6(5) 1316-1320 2017年5月査読有り
Cell-Surface MMP-9 Protein Is a Novel Functional Marker to Identify and Separate Proangiogenic Cells from Early Endothelial Progenitor Cells Derived from CD133(+) Cells

Toshie Kanayasu-Toyoda, Takeshi Tanaka, Yutaka Kikuchi, Eriko Uchida, Akifumi Matsuyama, Teruhide Yamaguchi

STEM CELLS 34(5) 1251-1262 2016年5月
遺伝子治療関連法規

山口照英, 内田恵理子

「細胞治療認定管理師制度認定カリキュラム」 28-38 2016年査読有り
2015 Guidance on cancer immunotherapy development in early-phase clinical studies

Teruyo Arato, Yoshiyuki Yamaguchi, Takashi Daimon, Yuji Heike, Ken Ishii, Kouji Kobiyama, Kyogo Itho, Shinichi Kageyama, Hiroshi Shiku, Yoshihiro Miyahara …

Cancer Science 106(12) 1761-1771 2015年12月1日査読有り
Angiogenic Role of MMP-2/9 Expressed on the Cell Surface of Early Endothelial Progenitor Cells/Myeloid Angiogenic Cells

Toshie Kanayasu-Toyoda, Takeshi Tanaka, Akiko Ishii-Watabe, Hiroko Kitagawa, Akifumi Matsuyama, Eriko Uchida, Teruhide Yamaguchi

JOURNAL OF CELLULAR PHYSIOLOGY 230(11) 2763-2775 2015年11月査読有り
Regulatory Frameworks for Gene and Cell Therapies in Japan.

Daisuke Maeda, Teruhide Yamaguchi, Takami Ishizuka, Masakazu Hirata, Kazuhiro Takekita, Daisaku Sato

Advances in experimental medicine and biology 871 147-62 2015年
日本薬局方参考情報収載マイコプラズマ否定試験のPCR法改正のための共同研究

内田恵理子, 古田美玲, 菊池裕, 窪崎敦隆, 遊佐精一, 宮原美知子, 佐々木裕子, 小原有弘, 大谷梓, 松山晃文 …

マイコプラズマ学会雑誌 41 43-44 2015年査読有り
モノクローナル抗体医薬品の現状と将来展望—Current situations and the future prospect of monoclonal antibody products

山口照英

国立医薬品食品衛生研究所報告 = Bulletin of National Institute of Health Sciences (132) 36-46 2014年